Trial Profile
Phase I trial of intranasal ALN RSV01 in volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2012
Price :
$35
*
At a glance
- Drugs Asvasiran sodium (Primary)
- Indications Respiratory syncytial virus infections
- Focus Adverse reactions; Pharmacokinetics
- 08 May 2007 Results have been reported.
- 24 Jan 2006 New trial record.